Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLASTIHC: Intermittent Hypoxic Conditioning Following Stroke
NCT05210088Phase 2Withdrawn
- Sponsor
- CHU Grenoble Alpes
- Start
- Jan 2024
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke (3 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Secondary adverse events at 8 weeks. Planned start Jan 2024; status: withdrawn.
02
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05210088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05210088.